Brief: G1 Therapeutics Provides First Quarter 2022 Financial Results

G1 Therapeutics

04/05/2022 14:06

May 4 (Reuters) - G1 Therapeutics Inc  GTHX.O :
    * G1 THERAPEUTICS PROVIDES FIRST QUARTER 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q1 LOSS PER SHARE $1.15
    * Q1 REVENUE $6.9 MILLION
    * EXPECTS CURRENT CASH POSITION OF $183.0 MILLION TO BE
SUFFICIENT
TO FUND ITS OPERATIONS AND CAPITAL EXPENDITURES INTO 2024

Source text for Eikon:  ID:nGNX2LnGGt 
Further company coverage:  GTHX.O 

 ((reuters.briefs@thomsonreuters.com;))